Craft

Ribon Therapeutics

Total Funding

$65 M

Ribon Therapeutics Summary

Company Summary

Overview
Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells’ fundamental ability to survive under stress
Type
Private
Status
Active
Founded
2015
Website
http://www.ribontx.com/
Cybersecurity rating
Sectors

Key People

  • James E. Audia, Member of the Board

    • Sally Johnson

      Sally Johnson, Chief People Officer

    • Jodie Morrison

      Jodie Morrison, Chair of the Board Of Directors

    • Laura Brass

      Laura Brass, Member of the Board

    Footer menu